rhesu
rotaviru
vaccin
adjuv
iscom
inject
intramuscularli
pregnant
baboon
repeat
dose
week
deliveri
matern
blood
milk
sampl
blood
sampl
babi
collect
interv
week
parturit
sampl
assay
rotaviru
antibodi
elisa
neutralis
test
vaccin
produc
statist
signific
increas
matern
serum
igg
neutralis
antibodi
milk
iga
igg
neutralis
antibodi
control
baboon
mother
sampl
week
deliveri
lower
serum
milk
antibodi
titr
respond
vaccin
week
produc
similar
antibodi
projil
serum
milk
previous
vaccin
endem
natur
human
rotavir
infect
similar
matern
vaccin
potenti
mean
increas
milk
antibodi
level
may
protect
infant
rotaviru
import
caus
sever
diarrhoea
children
worldwid
similar
signific
caus
neonat
diarrhoea
mani
domest
anim
develop
rotavir
vaccin
accord
high
prioriti
emphasi
live
vaccin
oral
deliveri
young
child
stimul
consider
research
use
particularli
rotavirus
anim
origin
genet
reassort
virus
mix
animalhuman
strain
princip
problem
encount
serotyp
specif
immun
respons
necessit
inclus
multipl
serotyp
difficulti
achiev
appropri
balanc
attenu
abil
replic
effect
date
safe
effect
vaccin
children
avail
situat
anim
rotavir
vaccin
rather
complex
first
modifi
live
calf
rotaviru
vaccin
develop
contemporari
compar
trial
consist
fail
demonstr
protect
result
popular
approach
cattl
matern
parenter
vaccin
stimul
secret
specif
antibodi
colostrum
milk
take
advantag
fact
rotaviru
antibodi
present
lumen
intestin
effect
mediat
protect
vaccin
base
concept
proven
efficaci
perhap
due
insuffici
antigen
poor
adjuvant
sever
effect
commerci
success
vaccin
cattl
exist
proven
field
number
year
develop
rotavir
vaccin
pig
year
behind
cattl
stage
mix
result
potenti
signific
advantag
matern
vaccin
heterotyp
natur
immun
respons
adult
wide
previou
exposur
endem
rotavir
infect
children
young
anim
encount
first
rotaviru
infect
mount
immun
respons
larg
serotypespecif
term
vitro
assay
vivo
protect
contrast
adult
endem
exposur
stimul
infect
vaccin
produc
immun
respons
wide
rang
serotyp
heterotyp
respons
suffici
magnitud
obviat
need
multiserotyp
vaccin
matern
vaccin
schedul
success
cattl
vaccin
contain
typic
one
strain
viru
confer
protect
multipl
strain
present
field
addit
area
parenter
matern
vaccin
potenti
advantag
provis
protect
neonat
safeti
use
inactiv
vaccin
background
decid
undertak
experi
attempt
manipul
antibodi
respons
rotaviru
milk
nonhuman
primat
ascertain
potenti
advantag
passiv
immunis
mother
could
realis
speci
phylogenet
relat
man
group
pregnant
multipar
oliv
baboon
papio
anubi
postdeliveri
weight
rang
kg
maintain
institut
primat
research
ipr
facil
use
princip
receiv
rotaviru
vaccin
hous
group
cage
control
deliveri
babi
remain
wean
termin
experi
month
anim
coloni
serum
antibodi
rhesu
rotaviru
viru
neutralis
assay
indic
previou
natur
intestin
exposur
anim
sedat
intramuscular
inject
ml
mixtur
mgml
keta
mine
hydrochlorid
park
davi
xylazin
bayer
prior
handl
studi
review
approv
institut
ipr
scientif
resourc
evalu
review
committe
simian
rotaviru
rrv
strain
lot
cultiv
rhesu
monkey
diploid
cell
produc
dyncorp
trial
man
kindli
provid
dr
lou
potash
viru
passag
cell
harvest
extract
gpr
bdh
infect
titr
extract
cultur
fluoresc
focu
unit
ffu
ml
protein
concentr
mgml
mockinfect
cultur
prepar
similarli
detect
infect
protein
content
mgml
vaccin
placebo
adjuv
ad
ugj
ml
iscom
matrix
manufactur
iscotec
kindli
provid
dr
b
sundquist
vaccin
store
month
c
subsequ
month
administ
deep
intramuscular
inject
without
evid
local
reaction
discomfort
princip
vaccin
initi
week
parturit
receiv
second
third
vaccin
dose
week
deliveri
respect
blood
serum
collect
initi
vaccin
deliveri
interv
wean
approxim
month
occas
deliveri
milk
also
collect
babi
bled
serum
sampl
control
initi
week
deliveri
point
sampl
collect
mother
babi
vaccine
control
receiv
initi
vaccin
dose
week
deliveri
isotypespecif
elisa
utilis
microtitr
plate
nunc
maxisorb
coat
rabbit
antirotaviru
captur
serum
neg
antigen
test
control
sampl
horseradish
peroxidaseconjug
rabbit
antimonkey
igg
sigma
rabbit
antihuman
iga
dako
colour
develop
ad
substrat
ophenylenediamin
dihydrochlorid
bound
peroxidas
reaction
stop
absorb
measur
mu
net
absorb
calcul
subtract
valu
neg
antigen
well
correspond
well
pool
consist
postvaccin
serum
baboon
assay
eight
dilut
plate
igg
iga
elisa
net
absorb
function
arbitrari
antibodi
unit
fit
linlog
sigmoid
curv
pool
use
initi
dilut
igg
iga
elisa
respect
case
produc
curv
fit
r
final
dilut
differ
absorb
posit
neg
antigen
result
paramet
use
extrapol
antibodi
unit
test
sampl
take
consider
rel
dilut
factor
sampl
test
viru
neutralis
assay
rotavirus
wa
typic
human
viru
serotyp
perform
microtitr
plate
endpoint
determin
reduct
ffu
comparison
group
made
twosampl
ltest
use
minitab
softwar
group
pregnant
baboon
respond
initi
vaccin
mean
increas
serum
antibodi
titr
week
deliveri
assay
igg
elisa
homotyp
vnt
heterotyp
wa
vnt
respect
tabl
increas
signific
p
signific
serum
iga
antibodi
respons
p
elev
igg
vn
titr
show
small
increas
repeat
immunis
week
postdeliveri
respons
rrv
vnt
boost
reach
signific
p
otherwis
titr
maintain
approxim
constant
level
throughout
lactat
increas
observ
week
iga
wa
titr
signific
p
serum
titr
control
group
vaccin
first
time
week
parturit
show
signific
p
increas
igg
homotyp
heterotyp
vn
iga
titr
although
trend
appar
possibl
certain
effect
vaccin
milk
antibodi
profil
earli
lactat
due
unforeseen
problem
control
anim
sampl
week
deliveri
howev
week
onward
direct
comparison
possibl
mean
igg
elisa
titr
vaccin
group
vari
within
narrow
limit
throughout
lactat
tabl
titr
low
serum
titr
howev
period
week
vaccin
anim
mean
group
igg
elba
vaccine
control
iga
elisa
vaccine
control
vnt
rrv
vaccine
control
vnt
wa
vaccine
control
solid
arrowstim
vaccin
princip
open
arrowstim
vaccin
control
igg
titr
observ
control
indic
signific
boost
vaccin
jj
control
respond
rapidli
vaccin
week
signific
increas
igg
titr
approxim
level
vaccin
group
respons
alreadyvaccin
group
titr
also
signific
p
iga
titr
colostr
sampl
taken
first
week
lactat
high
ratio
concurr
serum
titr
valu
halv
follow
week
maintain
level
week
lactat
titr
higher
control
pc
subsequ
vaccin
control
week
significantli
c
elev
milk
iga
titr
level
similar
vaccine
alreadyvaccin
anim
milk
iga
respons
repeat
immunis
week
mean
vn
titr
rrv
milk
immunis
anim
show
similar
pattern
initi
colostr
titr
fall
approxim
half
remain
constant
rest
lactat
month
lactat
titr
significantli
higher
control
increas
control
titr
rrv
signific
mean
vn
titr
wa
remain
low
throughout
matern
deriv
antibodi
detect
sera
babi
immunis
mother
igg
elisa
vnt
tabl
transmiss
iga
taken
place
vn
titr
wane
undetect
level
week
birth
lack
respons
babi
probabl
indic
rotaviru
circul
coloni
period
observ
igg
antibodi
virusneutralis
activ
vaccin
anim
howev
greater
signific
observ
simpl
parenter
immunis
also
stimul
increas
iga
product
mammari
gland
due
fault
experiment
procedur
milk
collect
control
group
week
lactat
accur
definit
extent
iga
antibodi
earli
lactat
rais
made
howev
period
week
compar
sampl
obtain
iga
igg
rrv
vn
antibodi
enhanc
immunis
group
potenti
success
immunis
even
lactat
shown
vaccin
control
group
week
produc
increas
particularli
iga
titr
group
vaccin
control
loo
loo
loo
vaccin
control
lo
lo
vaccin
lo
lo
control
lo
lo
iga
elisa
titr
sampl
c
anim
studi
invalu
demonstr
intim
relationship
antibodi
product
mammari
gland
prior
intestin
antigen
exposur
thu
make
approach
stimul
milk
antibodi
product
specif
endem
enter
infect
particularli
appropri
mani
key
featur
relationship
elucid
studi
transmiss
gastroenter
tge
swine
sever
coronavir
enter
secretori
iga
domin
immunoglobulin
isotyp
postcolostr
sow
milk
siga
local
produc
mammari
gland
plasma
cell
whose
precursor
origin
intestin
tract
migrat
socal
gutmamm
ari
axi
enhanc
effect
antibodi
secret
milk
depend
prior
stimul
local
intestin
immun
herd
endem
tge
parenter
vaccin
sow
lead
boost
milk
sl
ga
improv
protect
piglet
fed
rotavirus
endem
swine
could
expect
parenter
rotavir
vaccin
sow
would
similarli
lead
boost
milk
siga
titr
confirm
passiv
immunis
piglet
fed
milk
delay
onset
shorten
durat
rotaviru
shed
diarrhoea
comparison
rumin
speci
less
instruct
anim
major
immunoglobulin
colostrum
iggl
select
transport
serum
postcolostr
milk
low
level
immunoglobulin
predominantli
iggl
howev
spite
appar
unpromis
obstacl
rotaviru
passiv
immunis
increas
titr
iggl
colostr
milk
antibodi
respons
cow
vaccin
remain
le
substanti
efficaci
commerci
success
develop
rotaviru
immunoprophylaxi
effici
transfer
utero
immunoglobulin
human
mother
foetu
contrast
almost
total
agammaglobulinaem
state
newborn
ungul
compens
ungul
earli
colostr
immunoglobulin
content
larg
igg
howev
postcolostr
stage
human
milk
ig
profil
typic
monogastr
anim
iga
addit
man
anim
precursor
mammari
gland
plasmocyt
origin
intestin
tract
migrat
mammari
would
anticip
lead
product
milk
iga
specif
rotaviru
endem
nonintestin
pathogen
herp
simplex
record
attempt
stimul
increas
secret
specif
iga
lactat
women
scanti
evid
suggest
occurr
otherwis
prior
intestin
antigen
exposur
key
factor
determin
lacteal
respons
parenter
vaccin
classic
experi
svennerholm
gave
subcutan
inject
wholecel
cholera
vaccin
swedish
asian
women
swede
anticip
previou
cholera
exposur
inde
low
neg
preexist
antibodi
titr
asian
women
endem
area
natur
exposur
could
anticip
although
vaccin
stimul
increas
serum
igg
group
mother
prior
intestin
exposur
produc
signific
titr
milk
iga
antibodi
subsequ
prospect
studi
confirm
protect
symptomat
cholera
infect
suck
infant
associ
higher
level
antibodi
breast
systemat
record
rotavir
milk
antibodi
profil
throughout
lactat
major
women
secret
antibodi
detect
iga
elisa
vn
assay
first
week
lactat
lower
proport
individu
continu
secret
antibodi
mani
month
occasion
increas
titr
observ
presum
respons
intestin
protect
role
breastfeed
childhood
rotavir
diarrhoea
best
controversi
potenti
passiv
immunis
matern
vaccin
receiv
scanti
attent
protect
rotavir
infect
immedi
postnat
period
lactat
effect
clearli
limit
best
suggest
clinic
cours
infect
rate
may
modifi
milk
antibodi
higher
milk
antibodi
titr
may
interfer
vaccin
commonli
possibl
demonstr
protect
effect
human
milk
rotavir
howev
optimist
assess
potenti
passiv
immunis
matern
immunis
drawn
consider
anim
experi
artifici
feed
infant
natur
titr
antibodi
milk
endem
infect
cow
sow
also
protect
boost
matern
vaccin
level
demonstr
protect
field
passiv
protect
outcom
mainten
adequ
concentr
antibodi
intestin
period
time
crucial
depend
protect
potenti
ingest
antibodi
ampli
demonstr
therefor
seem
stimul
antibodi
baboon
milk
r
snodgrass
et
al
reason
postul
milk
antibodi
titr
could
suffici
stimul
vaccin
protect
effect
may
ensu
iscom
matrix
select
appropri
adjuv
suitabl
wide
rang
speci
includ
primat
furthermor
activ
iscom
matrix
immunolog
well
characteris
prepar
virtual
nontox
quillaja
compon
even
given
high
preliminari
result
simpl
experi
endem
infect
baboon
show
nonhuman
primat
rotaviru
vaccin
adjuv
iscom
safe
effect
rais
serum
antibodi
igg
vn
titr
vaccin
heterolog
rotavirus
signific
iga
vn
antibodi
titr
also
present
milk
titr
higher
endem
infect
unvaccin
control
iga
respons
suggest
local
antibodi
product
mammari
gland
elicit
prior
intestin
exposur
anim
rotaviru
antigen
vn
titr
rais
consist
iga
titr
attempt
use
sensit
neutralis
assay
plaqu
reduct
epitop
block
use
neutralis
monoclon
would
warrant
studi
necessari
optimis
enhanc
lacteal
antibodi
investig
protect
potenti
one
potenti
disadvantag
approach
could
loss
protect
effect
neonat
rotavir
infect
subsequ
childhood
howev
like
passiv
ingest
antibodi
would
allow
limit
replic
viru
subclin
infect
thu
allow
develop
immun
rather
confer
complet
protect
infect
view
difficulti
develop
effect
oral
immunis
children
develop
countri
also
relev
assess
signific
result
human
vaccin
